Diagnostic utility of CT for suspected immune checkpoint inhibitor enterocolitis by Michael Dougan, Meghan J Mooradian, Leyre Zubiri, Sienna M Durbin, Nisanard Pisuchpen, Donald F Chute, Florian Johannes Fintelmann, Avinash Kambadakone

Get full text

Mucosal inflammation predicts response to systemic steroids in immune checkpoint inhibitor colitis by Melissa Lumish, Ryan J. Sullivan, Douglas B. Johnson, Michael Dougan, Anita Giobbie-Hurder, Meghan J Mooradian, Daniel Y Wang, Alexandra Coromilas, Tianqi Chen

Get full text

Tumor location as a risk factor for severe immune-related adverse events by Mike Wang, Michael Dougan, Daniel Leonard, Leyre Zubiri, Ryan J Sullivan, Kerry L Reynolds, Donald P Lawrence, Kamil Slowikowski, Alexandra-Chloe Villani, Steven M Blum, Ben Ouyang, Kelley A Grealish, Nora K Hathaway, Gabriel Molina, Nishi Shah, Mari Mino Kendusen

Get full text

An open-label phase II trial of sotrovimab (VIR-7831) prophylaxis against COVID-19 infection in immunocompromised individuals with impaired SARS-CoV-2 humoral immunity by Isabel H. Gonzalez-Bocco, Rayven Frierson, Alyssa Cho, Fabiola A. Reyes Curcio, Andres E. Franceschi, Chloe Lahoud, Dimitrios G. Moshovitis, Katherine Beluch, Manu Balusu, C. Elizabeth Keleher, Keri M. Sullivan, Michael Dougan, Qianwen Wang, Jennifer H. Han, Ahmed Nader, Alicia Aylott, Wei Wang, Brian T. Chan, Sarah P. Hammond, Jennifer Manne-Goehler, Sophia Koo

Get full text